Dermtek Pharma
Pharmaceutical Manufacturing • 
Montreal, Quebec, Canada • 21-50 Employees
Company overview
| Headquarters | 7600 Transcanada Hwy, POINTE-CLAIRE, QC H9R 1C8, CA |
| Phone number | +15146853333 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Skin Care, Pharmaceutical, Glycolic Acid, Therapeutic Dermatology |
| Founded | 1985 |
| Employees | 21-50 |
| Socials |
Key Contacts at Dermtek Pharma
Pierre Simard
Scientific Director
Lora Spiga
Director Sales And Education
Dermtek Pharma Email Formats
Dermtek Pharma uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@dermtek.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@dermtek.com | 50% |
{first name}{last name} | johndoe@dermtek.com | 50% |
About Dermtek Pharma
RESEARCHING EXCELLENCE: A uniquely Canadian manufacturing company, Quebec-based Dermtek Pharma distinguishes itself through its commitment to designing formulations that will only further the art of dermatology. Scientifically formulating innovative products to ensure maximum efficacy, product safety and high patient compliance is an overall philosophy that is applied to every development project. Dermtek is particularly proud to be a family-owned developer and supplier of proven and effective research- based dermatological formulations. Founded in 1986, Dermtek Pharma was the first completely Canadian pharmaceutical company specializing in the development and manufacturing of dermatological products. The creation of sun protection trailblazer Ombrelle in 1990, later acquired by L’Oréal, led to the emergence of the Reversa brand. ● À LA RECHERCHE DE L'EXCELLENCE : Chef de file en dermocosmétique au Canada, Dermtek Pharma, un fabricant pharmaceutique de propriété entièrement canadienne, se distingue par son engagement et sa volonté de concevoir des produits qui repoussent les limites de l’art de la dermatologie. Les principes qui sous-tendent notre philosophie d’entreprise sont de développer de façon scientifique des produits innovants offrant une efficacité maximale et une totale innocuité, tout en favorisant la meilleure adhésion au traitement. Dermtek est particulièrement fière d’être une entreprise familiale qui conçoit et fournit des formules dermatologiques efficaces issues de la recherche. Fondée en 1986, Dermtek Pharma a été la première compagnie pharmaceutique entièrement canadienne à se spécialiser dans le développement et la fabrication de produits dermatologiques. La création de l’écran solaire Ombrelle en 1990, éventuellement vendue à L’Oréal, a naturellement mené au développement de la gamme Reversa.
Dermtek Pharma revenue & valuation
| Annual revenue | $2,481,095 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $8,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Dermtek Pharma has 10 employees across 3 departments.
Departments
Number of employees
Funding Data
Dermtek Pharma has never raised funding before.
Dermtek Pharma Tech Stack
Discover the technologies and tools that power Dermtek Pharma's digital infrastructure, from frameworks to analytics platforms.
RUM
Translation
Payment processors
CDN
JavaScript libraries
Miscellaneous
Security
Payment processors
JavaScript libraries
Payment processors
JavaScript libraries
India
United States
Frequently asked questions
4.8
40,000 users
